M-M-RVAXPRO powder and solvent for injectable suspension

Roman Raevskii

Dr. Roman Raevskii is a licensed general practitioner in Spain, offering online medical consultations with a strong focus on prevention, early diagnosis, and personalized care. He combines evidence-based clinical expertise with a patient-centered approach to deliver comprehensive support.

Dr. Raevskii provides medical care in the following areas:

Diagnosis and management of common conditions: hypertension, diabetes, respiratory and digestive disorders.
Oncological consultations: early cancer detection, risk evaluation, and treatment navigation.
Supportive care for oncology patients – pain control, symptom relief, and side effect management.
Preventive medicine and health screenings.
Development of tailored treatment plans based on clinical guidelines.

With a patient-centred approach, Dr. Raevskii helps individuals manage both chronic illnesses and complex oncological cases. His consultations are guided by current medical standards and adapted to each patient’s needs.

General medicine21 years of experience

Hocine Lokchiri

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

fever, chills, fatigue and viral symptoms
cough, sore throat, nasal congestion, breathing discomfort
bronchitis and mild asthma flare-ups
nausea, diarrhoea, abdominal pain, digestive infections
rashes, allergic reactions, redness, insect bites
muscle or joint pain, mild injuries, sprains
headache, dizziness, migraine symptoms
stress-related symptoms, sleep disturbances
questions about test results and treatment plans
management of chronic conditions in stable phases

Dr. Lokchiri’s professional training includes:

Advanced Trauma Life Support (ATLS)
Basic and Advanced Cardiac Life Support (BLS/ACLS)
Pediatric Advanced Life Support (PALS)
Prehospital Trauma Life Support (PHTLS)
eFAST and critical care transthoracic echocardiography
aviation medicine

Roman Raevskii

Dr. Raevskii provides medical care in the following areas:

Diagnosis and management of common conditions: hypertension, diabetes, respiratory and digestive disorders.
Oncological consultations: early cancer detection, risk evaluation, and treatment navigation.
Supportive care for oncology patients – pain control, symptom relief, and side effect management.
Preventive medicine and health screenings.
Development of tailored treatment plans based on clinical guidelines.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.

How to use M-M-RVAXPRO powder and solvent for injectable suspension

Introduction

Package Leaflet: Information for the User

M-M-RvaxPro

Powder and solvent for suspension for injection

Measles, mumps and rubella vaccine (live viruses)

Read all of this leaflet carefully before you or your child is vaccinated because it contains important information for you or your child.

Keep this leaflet, you may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

What M-M-RvaxPro is and what it is used for
What you need to know before you receive M-M-RvaxPro
How to use M-M-RvaxPro
Possible side effects
Storage of M-M-RvaxPro
Contents of the pack and other information

1. What M-M-RvaxPro is and what it is used for

M-M-RvaxPro is a vaccine containing weakened viruses of measles, mumps and rubella. When the vaccine is given to a person, the immune system (the body's natural defenses) will create antibodies against the measles, mumps and rubella viruses. The antibodies help protect against infections caused by these viruses.

M-M-RvaxPro is given to help protect you or your child against measles, mumps and rubella. The vaccine can be given to people aged 12 months or older. M-M-RvaxPro can be given, in special circumstances, to children aged 9 to 12 months.

M-M-RvaxPro may also be used during measles outbreaks, for post-exposure vaccination, or for use in people over 9 months who have not been previously vaccinated and are in contact with susceptible pregnant women, and people who are likely to be susceptible to mumps and rubella.

Although M-M-RvaxPro contains live viruses, they are too weak to cause measles, mumps or rubella in healthy individuals.

2. What you need to know before you receive M-M-RvaxPro

Do not useM-M-RvaxPro

if the person to be vaccinated is allergic to any measles, mumps or rubella vaccine or to any of the other components of this vaccine (listed in section 6) including neomycin.
if the person to be vaccinated is pregnant (also, pregnancy should be avoided for 1 month after vaccination, see Pregnancy and breast-feeding).
if the person to be vaccinated has any illness with fever over 38.5 °C; however, a slight fever is not in itself a reason to delay vaccination.
if the person to be vaccinated has untreated active tuberculosis.
if the person to be vaccinated has a blood disorder or any type of cancer that affects the immune system.
if the person to be vaccinated is receiving treatment or taking medicines that may weaken the immune system (except for low-dose corticosteroid therapy for asthma or replacement therapy).
if the person to be vaccinated has an immune system weakened by any disease (including AIDS).
if the person to be vaccinated has a family history of congenital or hereditary immunodeficiency, unless the immune competence of the person to be vaccinated is demonstrated.

Warnings and precautions

Talk to your doctor or pharmacist before the person to be vaccinated receives M-M-RvaxPro if they have experienced any of the following:

a severe allergic reaction to egg or any egg-containing product.
personal or family history of allergies or convulsions (fits).
a side effect after vaccination with measles, mumps and/or rubella vaccine that involves bruising or bleeding more than usual.
HIV infection without symptoms of HIV disease. The person to be vaccinated should be closely monitored during vaccination against measles, mumps and rubella, which may be less effective than for uninfected individuals (see section Do not use M-M-RvaxPro).

As with other vaccines, M-M-RvaxPro may not completely protect all vaccinated persons. Also, if the person to be vaccinated has already been exposed to measles, mumps or rubella virus but has not yet developed the disease, M-M-RvaxPro may not be able to prevent the disease from appearing.

M-M-RvaxPro can be given to people who have recently (within the last 3 days) been in contact with a case of measles and may be incubating the disease. However, in these cases, M-M-RvaxPro may not be able to prevent the development of measles.

Using M-M-RvaxPro with other medicines

Tell your doctor or pharmacist if the person to be vaccinated is using or has recently used other medicines (or other vaccines).

Your doctor may delay vaccination for at least 3 months after a blood or plasma transfusion or after the administration of immunoglobulin (known as Ig). After vaccination with M-M-RvaxPro, Ig should not be given for 1 month, unless your doctor tells you otherwise.

If a tuberculin test is to be done, it should be done at any time before, at the same time as, or 4 to 6 weeks after vaccination with M-M-RvaxPro.

M-M-RvaxPro can be given at the same time as Prevenar and/or hepatitis A vaccine in a different injection site (e.g. the other arm or leg).

M-M-RvaxPro can be given with some routine infant vaccines as they may need to be given at the same time. For vaccines that cannot be given at the same time, M-M-RvaxPro should be given 1 month before or after the administration of these vaccines.

Pregnancy and breast-feeding

M-M-RvaxPro should not be given to pregnant women. Women of childbearing age, after being vaccinated, should take precautions to avoid pregnancy for 1 month, or as recommended by their doctor.

Tell your doctor if you are breast-feeding or are planning to breast-feed. Your doctor will decide whether you should receive M-M-RvaxPro.

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this vaccine.

Driving and using machines

There is no information to suggest that M-M-RvaxPro affects the ability to drive or use machines.

M-M-RvaxPro contains sodium

This medicine contains less than 1 mmol of sodium (23 milligrams) per dose, i.e. it is essentially “sodium-free”.

M-M-RvaxPro contains potassium

This medicine contains potassium, less than 1 mmol (39 milligrams) per dose; it is essentially “potassium-free”.

M-M-RvaxPro contains sorbitol (E-420)

This medicine contains 14.5 milligrams of sorbitol per dose. The additive effect of medicines containing sorbitol (or fructose) administered concomitantly and the intake of sorbitol (or fructose) in the diet should be taken into account.

3. How to use M-M-RvaxPro

M-M-RvaxPro should be injected into the muscle or under the skin in the outer aspect of the thigh or upper arm. For intramuscular injections, the thigh is the recommended site in young children, while the upper arm is the recommended site in older individuals. M-M-RvaxPro should not be injected into any blood vessel.

M-M-RvaxPro should be administered as follows:

A single dose on the selected date, usually from 12 months of age. In special circumstances, it can be given from 9 months of age. Additional doses should be given according to the doctor's recommendations. The interval between 2 doses should be at least 4 weeks.

Instructions for reconstitution intended for medical or healthcare professionals are included at the end of the leaflet.

4. Possible side effects

Like all medicines, this vaccine can cause side effects, although not everybody gets them.

The following side effects were reported with the use of M-M-RvaxPro:

Frequency	Side effects
Very common (may affect more than 1 in 10 vaccinated)	Fever (38.5 °C or higher). Redness at the injection site, pain at the injection site and swelling at the injection site.

Frequency	Side effects
Common (may affect up to 1 in 10 vaccinated)	Rash (including measles-like rash). Bruising at the injection site.
Uncommon (may affect up to 1 in 100 vaccinated)	Nasal congestion, sore throat, upper respiratory tract infection or viral infection, runny nose. Crying. Diarrhea, vomiting. Hives. Rash at the injection site.
Frequency not known (frequency cannot be estimated from the available data)	Aseptic meningitis (fever, feeling unwell, vomiting, headache, stiff neck and sensitivity to light), swollen testicles, middle ear infection, swollen salivary glands, atypical measles (described in patients who received a killed measles virus vaccine, administered normally before 1975). Swollen lymph nodes. Bruising or bleeding more easily than usual. Severe allergic reaction that can include difficulty breathing, facial swelling, localized swelling and swelling of the limbs. Irritability. Seizures (fits) without fever, seizures (fits) with fever in children, unsteady walking, dizziness, disease involving inflammation of the nervous system (brain and/or spinal cord). Disease that involves muscle weakness, abnormal sensations, tingling in the arms, legs, and upper body (Guillain-Barré syndrome). Headache, fainting, disorder of the nerves that can cause weakness, tingling or numbness, eye nerve disorders. Discharge and itching in the eyes with crust formation on the eyelids (conjunctivitis). Inflammation of the retina (in the eye) with changes in vision. Deafness. Cough, lung infection with or without fever. Feeling sick (nausea). Itching, inflammation of the fatty tissue under the skin, small red or purple spots on the skin, skin patches, hardened skin, severe disease with ulcers or blisters on the skin, mouth, eyes, and/or genitals (Stevens-Johnson syndrome). Pain and/or swelling of the joints (usually transient and rarely chronic), muscle pain. Burning and/or itching of short duration at the injection site, blisters and/or hives at the injection site. General feeling of being unwell, swelling and pain. Inflammation of blood vessels.

These side effects were reported with the administration of both M-M-RvaxPro and the measles, mumps and rubella vaccine manufactured by Merck & Co., Inc, as well as their monovalent (individual) components during post-marketing use and/or during clinical trials.

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of M-M-RvaxPro

Keep out of sight and reach of children.

Do not use this vaccine after the expiry date which is stated on the outer packaging after EXP. The expiry date is the last day of the month stated.

Store and transport refrigerated (between 2 °C and 8 °C).

Store the powder vial in the outer packaging to protect it from light.

Do not freeze the vaccine.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Container contents and additional information

M-M-RvaxPro composition

The active ingredients are:

After reconstitution, one dose (0.5 ml) contains:

Measles virus Enders’ Edmonston strain (live, attenuated)	not less than 1 x 10^3 TCID50*
Mumps virus Jeryl Lynn strain [Level B] (live, attenuated)	not less than 12.5 x 10^3 TCID50*
Rubella virus Wistar RA 27/3 strain (live, attenuated)	not less than 1 x 10^3 TCID50*

Dose that infects 50% of tissue cultures.

1 Produced in chicken embryo cells.

2 Produced in human diploid lung fibroblasts (WI-38).

The other components are:

Powder:

Sorbitol (E-420), sodium phosphate (NaH2PO4/Na2HPO4), potassium phosphate (KH2PO4/K2HPO4), sucrose, hydrolyzed gelatin, 199 medium with Hanks' salts, MEM, monosodium L-glutamate, neomycin, phenol red, sodium bicarbonate (NaHCO3), hydrochloric acid (HCl) (for pH adjustment) and sodium hydroxide (NaOH) (for pH adjustment).

Solvent:

Water for injections.

Appearance of M-M-RvaxPro and container contents

The vaccine is a powder for injectable suspension contained in a single-dose vial, which must be mixed with the supplied solvent.

The solvent is a clear, colorless liquid. The powder is a compact, crystalline mass of pale yellow color.

M-M-RvaxPro is available in packs of 1, 5, and 10. Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Merck Sharp & Dohme B.V., Waarderweg 39, 2031 BN Haarlem, Netherlands

For further information about this medicinal product, please contact the local representative of the marketing authorization holder.

België/Belgique/Belgien

MSD Belgium

Tél/Tel: +32(0)27766211

Lietuva

UAB Merck Sharp & Dohme

Tel.: +370.5.2780.247

Text in Bulgarian language with company name Мерк Шарп и Доум България ЕООД and phone number +359 2 819 3737

Luxembourg/Luxemburg

MSD Belgium

Tél/Tel: +32(0)27766211

Ceská republika

Merck Sharp & Dohme s.r.o.

Tel.: +420 233 010 111

Magyarország

MSD Pharma Hungary Kft.

Tel.: + 36.1.888.5300

Danmark

MSD Danmark ApS

Tlf: + 45 4482 4000

Malta

Merck Sharp & Dohme Cyprus Limited.

Tel: 8007 4433 (+356 99917558)

Deutschland

MSD Sharp & Dohme GmbH

Tel: 0800 673 673 673 (+49 (0) 89 4561 0)

Nederland

Merck Sharp & Dohme B.V.

Tel: 0800 9999000

(+31 23 5153153)

Eesti

Merck Sharp & Dohme OÜ

Tel.: +372 6144 200

Norge

MSD (Norge) AS

Tlf: +47 32 20 73 00

Ελλ?δα

MSD Α.Φ.Β.Ε.Ε.

Τηλ: +30 210 98 97 300

Österreich

Merck Sharp & Dohme Ges.m.b.H.

Tel: +43 (0) 1 26 044

España

Merck Sharp & Dohme de España, S.A.

Tel: +34 91 321 06 00

Polska

MSD Polska Sp. z o.o.

Tel.: +48.22.549.51.00

France

MSD France

Tél: + 33 (0)1 80 46 40 40

Portugal

Merck Sharp & Dohme, Lda

Tel: +351 21 4465700

Hrvatska

Merck Sharp & Dohme d.o.o.

Tel: +385 1 66 11 333

România

Merck Sharp & Dohme Romania S.R.L

Tel: + 4021 529 29 00

Ireland

Merck Sharp & Dohme Ireland (Human Health) Limited

Tel: +353 (0)1 2998700

Slovenija

Merck Sharp & Dohme, inovativna zdravila d.o.o.

Tel: +386.1.520.4201

Ísland

Vistor hf.

Sími: + 354 535 7000

Slovenská republika

Merck Sharp & Dohme, s. r. o

Tel: +421 2 58282010

Italia

MSD Italia S.r.l.

Tel: 800 23 99 89 (+39 06 361911)

Suomi/Finland

MSD Finland Oy

Puh/Tel: +358 (0)9 804 650

Κúπρος

Merck Sharp & Dohme Cyprus Limited

Τηλ: 800 00 673 (+357 22866700)

Sverige

Merck Sharp & Dohme (Sweden) AB

Tel: +46 77 5700488

Latvija

SIA Merck Sharp & Dohme Latvija

Tel: +371.67364.224

United Kingdom (Northern Ireland)

Merck Sharp & Dohme Ireland (Human Health) Limited

Tel: +353 (0)1 2998700

M-M-RVAKSPRO VAKCINA DLA PROFILAKTIKI KORU, EPIDEMICNOGO PAROTITU TA KRASNUHI ZIVA

Date of last revision of this leaflet: <{MM/AAAA}><{month AAAA}>.

Other sources of information

Detailed information on this medicinal product is available on the European Medicines Agency website http://www.ema.europa.eu.

This information is intended for healthcare professionals only:

Before mixing with the solvent, the vaccine powder is a compact, crystalline mass of pale yellow color. The solvent is a clear, colorless liquid. When fully reconstituted, the vaccine is a clear yellow liquid.

For reconstitution of the vaccine, use the supplied solvent.

It is important to use a new, sterile syringe and needle for each patient to prevent the transmission of infectious agents from one person to another.

A separate needle should be used for reconstitution and a different needle for injection.

Reconstitution instructions

Withdraw the entire contents of the solvent vial into a syringe that will be used for reconstitution and injection. Inject the entire contents of the syringe into the vial containing the powder. Gently shake to mix completely.

The reconstituted vaccine should not be used if any foreign particles are observed or if the appearance of the solvent or powder or reconstituted vaccine differs from that described above.

After reconstitution, it is recommended to administer the vaccine immediately to minimize loss of potency or within 8 hours if stored in the refrigerator.

Do not freeze the reconstituted vaccine.

Withdraw the entire contents of the reconstituted vaccine from the vial into a syringe, change the needle, and inject the entire contents subcutaneously or intramuscularly.

Unused products or waste materials should be disposed of in accordance with local requirements.

See also section 3. How to use M-M-RvaxPro.

Country of registration
Spain
Active substance
measles, combinations with mumps and rubella, live attenuated
Prescription required
Yes
Manufacturer
Merck Sharp & Dohme B.V.
This information is for reference only and does not constitute medical advice. Always consult a licensed doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
Alternatives to M-M-RVAXPRO powder and solvent for injectable suspension
M-M-RVAXPRO Powder and Solvent for Injectable Suspension in Pre-filled Syringe
Active substance: measles, combinations with mumps and rubella, live attenuated
Manufacturer: Merck Sharp & Dohme B.V.
Prescription required
PRIORIX, POWDER AND SOLVENT FOR INJECTION IN PRE-FILLED SYRINGE
Dosage form: INJECTABLE, 0.5 ml
Active substance: measles, combinations with mumps and rubella, live attenuated
Manufacturer: Glaxosmithkline S.A.
Prescription required
PROQUAD powder and solvent for injectable suspension in pre-filled syringe
Dosage form: INJECTABLE, 3 Infectious dose 50% in tissue culture / 3 Infectious dose 50% in tissue culture / 4.3 Infectious dose 50% in tissue culture / 3.99 FIP U
Active substance: measles, combinations with mumps, rubella and varicella, live attenuated
Manufacturer: Merck Sharp & Dohme B.V.
Prescription required

Alternatives to M-M-RVAXPRO powder and solvent for injectable suspension in other countries

The best alternatives with the same active ingredient and therapeutic effect.

Alternative to M-M-RVAXPRO powder and solvent for injectable suspension in Poland

Priorix

Dosage form: Powder, -

Active substance: measles, combinations with mumps and rubella, live attenuated

Manufacturer: GlaxoSmithKline Biologicals S.A.

Prescription required

Alternative to M-M-RVAXPRO powder and solvent for injectable suspension in Ukraine

PRIORIKS KOMBINOVANA VAKCINA

Dosage form: lyophilizate, 1 single-dose vial

Active substance: measles, combinations with mumps and rubella, live attenuated

Manufacturer: GlaksoSmitKlajn Biolodzikalz S.A.

Prescription required

Dosage form: powder, 1 vial of powder (1 dose) and 1 vial of solvent (water for injection) of 0.7 ml

Active substance: measles, combinations with mumps and rubella, live attenuated

Manufacturer: Merk Sarp i Doum B.V.

Prescription required

VAKCINA DLA PROFILAKTIKI KORU, EPIDEMICNOGO PAROTITU TA KRASNUHI, ZIVA ATENUJOVANA

Dosage form: lyophilizate, 0.5 ml (1 dose)

Active substance: measles, combinations with mumps and rubella, live attenuated

Manufacturer: TOV "Farma Lajf

Prescription required

Online doctors for M-M-RVAXPRO powder and solvent for injectable suspension

Discuss dosage, side effects, interactions, contraindications, and prescription renewal for M-M-RVAXPRO powder and solvent for injectable suspension – subject to medical assessment and local rules.

0.0(0)

Hocine Lokchiri

General medicine21 years of experience

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

fever, chills, fatigue and viral symptoms
cough, sore throat, nasal congestion, breathing discomfort
bronchitis and mild asthma flare-ups
nausea, diarrhoea, abdominal pain, digestive infections
rashes, allergic reactions, redness, insect bites
muscle or joint pain, mild injuries, sprains
headache, dizziness, migraine symptoms
stress-related symptoms, sleep disturbances
questions about test results and treatment plans
management of chronic conditions in stable phases

Dr. Lokchiri’s professional training includes:

Advanced Trauma Life Support (ATLS)
Basic and Advanced Cardiac Life Support (BLS/ACLS)
Pediatric Advanced Life Support (PALS)
Prehospital Trauma Life Support (PHTLS)
eFAST and critical care transthoracic echocardiography
aviation medicine

Roman Raevskii

Dr. Raevskii provides medical care in the following areas:

Diagnosis and management of common conditions: hypertension, diabetes, respiratory and digestive disorders.
Oncological consultations: early cancer detection, risk evaluation, and treatment navigation.
Supportive care for oncology patients – pain control, symptom relief, and side effect management.
Preventive medicine and health screenings.
Development of tailored treatment plans based on clinical guidelines.

Family medicine15 years of experience

Svetlana Kovalenko

Dr Svetlana Kovalenko is a family medicine doctor with over 14 years of experience and a medical degree from Kharkiv National Medical University. She offers online consultations for adults, supporting patients with both acute and chronic conditions, preventive care, and personalised medical advice.

What patients commonly consult her for:

High blood pressure, type 2 diabetes, cholesterol management
Cold and flu symptoms: fever, cough, sore throat
Fatigue, sleep problems, headaches, general discomfort
Ongoing care for chronic conditions and medication review
Help interpreting test results and lab reports
Preventive check-ups and advice on healthy lifestyle habits

Dr Kovalenko combines evidence-based practice with a respectful, patient-centred approach. She takes time to explain, listens attentively, and helps each person make confident, informed decisions about their health.

Family medicine13 years of experience

Taisiya Minorskaya

Dr Taisiya Minorskaya is a family medicine doctor with an official licence to practise in Spain and over 12 years of clinical experience. She provides online consultations for adults and children, combining evidence-based medicine with a personalised, modern European approach.

She helps with:

Viral infections and cold symptoms (flu, sore throat, cough, runny nose)
Review and adjustment of antibiotics
Skin rashes and allergic reactions
Chronic condition flare-ups, high blood pressure, headaches, fatigue
Lab and test interpretation
Medication review and adaptation to European standards
Patient navigation: what tests are needed, which specialists to see, when an in-person visit is required

Dr Minorskaya also specialises in the diagnosis and management of gastrointestinal conditions, including bloating, abdominal pain, chronic nausea, IBS, and SIBO. She supports patients with unexplained physical symptoms that may be linked to somatisation or stress, helping them find relief and improve quality of life.

She offers care for people undergoing GLP-1 therapy (Ozempic, Mounjaro, and others) for weight management. Her support follows Spanish clinical guidelines, from treatment planning and side effect counselling to regular follow-ups and coordination with private or public healthcare providers.

Family medicine13 years of experience

Lina Travkina

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.

Areas of medical care include:

Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.
ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.
Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.
Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.
Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.
Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.
Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

Preventive consultations and check-up planning.
Medical advice and follow-up consultations.
Test interpretation and diagnostic guidance.
Structured support for undiagnosed complaints.
Second opinion on diagnoses and treatment plans.
Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.
Post-operative recovery support and pain management.
Preconception counselling and postpartum support.
Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.

If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

General medicine44 years of experience

Antonio Cayatte

Dr Antonio Cayatte is a physician in General and Acute Medicine with over 30 years of experience across clinical care, medical research, and education. He offers online consultations for adults with a wide range of symptoms, both acute and chronic.

His clinical background includes:

assessment of sudden or unclear symptoms
ongoing care for chronic conditions
follow-up after hospital discharge
interpretation of test results
medical support while abroad

Dr Cayatte earned his degree from the University of Lisbon and taught internal medicine at Boston University School of Medicine. He holds active medical registrations in both Portugal and the UK and is a Fellow of the American Heart Association.

Consultations are available in English and Portuguese. Patients value his clarity, professionalism, and balanced approach to evidence-based care.

General surgery12 years of experience

Yevgen Yakovenko

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

12+ years of clinical experience in university hospitals in Germany and Spain.
International education: Ukraine – Germany – Spain.
Member of the German Society of Surgeons (BDC).
Certified in radiological diagnostics and robotic surgery.
Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Andrei Popov

In addition to pain management, Dr. Popov helps patients with:

Dr. Andrei Popov is a licensed pain management specialist and general practitioner based in Spain. He provides expert online care for adults dealing with both chronic and acute pain, as well as a wide range of everyday health concerns.

He specialises in diagnosing and treating pain conditions that affect quality of life, including:

Chronic pain lasting more than 3 months.
Migraines and recurring headaches.
Neck, back, lower back, and joint pain.
Post-traumatic pain following injury or surgery.
Nerve-related pain, fibromyalgia, and neuralgia.

Respiratory infections (colds, bronchitis, pneumonia).
High blood pressure and metabolic conditions such as diabetes.
Preventive care and routine health check-ups.

Online consultations last up to 30 minutes and include a detailed symptom review, personalised treatment planning, and medical follow-up when needed.

Dr. Popov’s approach is rooted in evidence-based medicine, combined with individualised care tailored to each patient’s history, lifestyle, and clinical needs.

General medicine6 years of experience

Anna Biriukova

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
Leg swelling, chronic fatigue, reduced exercise tolerance.
EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
Post-COVID-19 cardiac monitoring and care.

Endocrinology – Diabetes, thyroid, metabolism:

Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
Individual treatment plans including oral medications and insulin therapy.
GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
Metabolic syndrome – obesity, lipid disorders, insulin resistance.

Gastroenterology – Digestive health:

Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).

General internal medicine and preventive care:

Respiratory infections – cough, colds, bronchitis.
Lab test analysis, therapy adjustments, medication management.
Adult vaccinations – planning, contraindications assessment.
Cancer prevention – screening strategies and risk assessment.
Holistic approach – symptom relief, complication prevention, and quality of life improvement.

Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.

Allergology7 years of experience

Alexander Nazarchuk

Dr. Alexander Nazarchuk is a physician specialising in allergology and internal medicine. He provides online consultations for adults, following the principles of evidence-based medicine — no outdated treatments or unnecessary tests, with clear explanations and a personalised approach. He helps patients with a wide range of allergic and therapeutic conditions, from common day-to-day complaints to complex cases involving allergies, gastrointestinal issues, cardiovascular concerns, respiratory symptoms, and more.

You can consult Dr. Nazarchuk for:

Test interpretation and guidance on diagnostic plans.
Allergic rhinitis, hay fever, bronchial asthma (including severe cases).
Food and drug allergies, skin rashes, angioedema.
Atopic dermatitis, urticaria, contact allergies.
Allergen-specific immunotherapy (AIT) – initiation and ongoing management.
Abdominal pain, bloating, changes in bowel habits, nausea, heartburn.
High blood pressure and adjustment of baseline antihypertensive therapy.
Hyperlipidaemia and elevated cholesterol.
Cough, nasal congestion, fever, sore throat.
Anaemia, including iron deficiency and related conditions.
Other issues related to allergology and internal medicine.

During consultations, Dr. Nazarchuk takes a thorough, structured approach — analysing symptoms, identifying potential causes, and helping patients make informed decisions. Whether treatment, further investigation, or monitoring is needed, he explains each step clearly so you understand your health and how best to manage it.